SuperTab® 40LL

Agglomerated anhydrous lactose and lactitol monohydrate

Excellent flow and compaction

High dilution potential

Oral Solid Dose
Supertab 40LL

Product information

The pharmaceutical industry is continuously looking, together with partners, at better ways to deliver medication to new patient groups. Mini-tablets are a great example as they allow pediatric and geriatric patients improved comfort in taking their medicines.

However, the economical production of mini-tablets does put a strain on the formulation. SuperTab® 40LL combines all required functionalities into one single excipient. Consequently, it breaks through the limits of direct compression, making it the excipient of choice for mini-tablet and / or other challenging formulations.

Product types
Granulated lactose, Anhydrous lactose, Co-processed
Excipient functionality
Filler-binder, Binder, Diluent
Recommended process
Direct compression, Continuous processing
Dosage forms
Tablet

Typical product data

Particle size distribution (μm)

X10
80
X50
180
X90
350

Bulk density (g/L)

Bulk density (g/L)
544

Hausner ratio (-)

Hausner ratio (-)
1.20

Documentation

  • ALBA Pharmaceutical lactose
  • Oral Solid Dose Brochure View
  • GMO Statement lactose
  • GMP+ DMV-Fonterra Excipients Nörten-Hardenberg
  • Halal DFE Pharma B.V. Borculo
  • ICHQ3D Elemental Impurities Lactose EU and NZ
  • Ingredient declaration lactose
  • MSDS Anhydrous lactose
  • MSDS Lactose monohydrate